PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,396 stories, page 35 of 807

Advanced search
🌍discoverynews.google.comTier 2 · Trade media

Exelixis Announces Third Quarter 2026 Financial Results and Provides Corporate Update

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Otsuka: Strong pharmaceutical growth lifted profit; FY2026 business profit guidance rose to ¥500bn

TradingViewOriginal source
🇮🇹Researchpoliclinico.mi.itTier 2 · Direct publisher

Malattie bilio-pancreatiche: il Policlinico di Milano si conferma Academy d'eccellenza

Policlinico di MilanoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kyongbo Pharmaceutical Q3 Operating Profit 100 Million Won, Down 79% From Year Earlier

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna CEO on the Biotech’s Cancer Vaccine and Pipeline

Barron'sOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Clinical Trial Evidence of Association between Antidopaminergic Medications and Clinical Measurements of Huntington’s Disease Progression Published in Neurology

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BIX 2026 Closes: From Brain Signals to Business Signals, Korea's Biotech Agenda Comes Into Focus

BioSpectrum AsiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SLS, IOVA, IBRX Slump In October As Biotech Stocks Hold Steady: Virginia Pension Fund Raised Stakes In All 3

Yahoo FinanceOriginal source
🌍Researchscience.orgTier 2 · Direct publisher

Early-career researchers’ right to unionize at NIH is upheld, against agency’s petition

ScienceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China vs US: The New War Over Cancer Drugs and Biotech Supremacy | The Morning Brief Decode

The Economic TimesOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Transformative Biotech Joins HudsonAlpha’s Primer Lab

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Bets on Three New Drugs for Up to $11 Billion in Peak Sales

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sun Pharma's ILUMYA gets USFDA approval for psoriatic arthritis treatment

Business StandardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sun Pharma's ILUMYA gets USFDA approval for psoriatic arthritis treatment

Business StandardOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Platelet Factor 4 (PF4) Radioimmunoassay Recall: Instrumentation Laboratories Removes HemosIL AcuStar HIT-IgG(PF4-H)

Product performance issue may lead to a false negative result which will delay recognition of hepari...

FDA MedWatchOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Hospital Glucose Meter Correction: Nova Biomedical Updates Use Instructions for StatStrip Glucose Hospital Meter Systems

Update use instructions for StatStrip Glucose Hospital Meter Systems due to the potential for glucos...

FDA MedWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sun Pharma stock in focus after US FDA approves drug for psoriatic arthritis

Business TodayOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Haier Biomedical Brings Blood Management and Pharmaceutical Cold Storage Expertise to AABB and ISPE 2026

BioSpaceOriginal source
🇺🇸Researchonlinelibrary.wiley.comTier 2 · Direct publisher

Atrial Leadless Pacing: A Potential Strategy for Cardioinhibitory Vasovagal Syncope

Pacing and Clinical ElectrophysiologyOriginal source
🇯🇵Regulatorypmda.go.jpTier 1 · Regulatory source

[ANZEN]PMDA Alert for Proper Use of Drugs: Request for Proper Use of GLP-1 Receptor Agonists and GIP/GLP-1 Receptor Agonists posted

PMDA JapanOriginal source
🇺🇸Industrythefdalawblog.comTier 3 · Secondary coverage

DEA Clarifies Direct Delivery of Prescribed Controlled Substances to Practitioners

Hyman, Phelps & McNamara (FDA Law)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

AeroSafe Global Convenes Healthcare Leaders to Address Pharmaceutical Cold-Chain Waste at Sustainability Symposium 2026

Gwinnett Daily PostOriginal source
🇯🇵Researchhosp.tohoku.ac.jpTier 2 · Direct publisher

2026年度 第4回東北大学病院脳卒中・心臓病等総合支援センター県民公開講座in柴田町開催のお知らせ（12/3開催）

Tohoku University HospitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bambusa raises $169M in Nasdaq debut, riding biotech IPO rebound

DealroomOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hanlim Pharm teams up with Japan's DCI Partners to explore biotech investments

Korea Biomedical ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dermatology Biotech Bambusa Raises $168.9 Million in US IPO

BloombergOriginal source
🇺🇸Industrybambusatx.comTier 1 · Company source

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Bambusa TherapeuticsOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Government steps up action on breast cancer

More than 1,000 people join trial testing shorter radiotherapy treatment, potentially saving patient...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Esophageal Squamous Cell Carcinoma Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

StreetInsiderOriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

AstraZeneca filed Form 6-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Gilead Sciences filed Form 10-Q

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Regeneron filed Form 10-Q

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Regeneron filed Form 8-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

AbbVie filed Form 8-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Sanofi filed Form 6-K

SEC EDGAROriginal source
🌍Researchnature.comTier 2 · Direct publisher

BAZ2A-induced epigenetic states in cancer cells fuel palmitate accumulation in the tumor microenvironment driving CAR-T cell exhaustion

Nature CancerOriginal source
🌍Researchnature.comTier 2 · Direct publisher

ANO6-mediated trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer cell growth and immune suppression

Nature CancerOriginal source
🌍Researchnature.comTier 2 · Direct publisher

GALE is a tumor-intrinsic checkpoint of Vγ9Vδ2 T cell-mediated killing

Nature CancerOriginal source
🌍Researchnature.comTier 2 · Direct publisher

Targeting GALE harnesses γδ T cells for cancer immunotherapy

Nature CancerOriginal source
🇺🇰Researchnature.comTier 2 · Direct publisher

Decoding small cell lung cancer vulnerabilities: the AI pathway to next-gen therapeutics

npj Precision OncologyOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: AIDS Drug Assistance Program-Transformation: Optimization and Best Practices in the Evolving Health Care Landscape, OMB No. 0906-XXXX-New

In compliance with the requirement for opportunity for public comment on proposed data collection pr...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Notice of Amended Order Requirement for Attestation by All Persons Arriving in the United States From Any Foreign Country Via Transportation by Aircraft and Controlled Free Pratique for Airlines and Other Aircraft Operators Confirming That Such Persons Have Not Been in the Democratic Republic of the

The Centers for Disease Control and Prevention (CDC), a component of the Department of Health and Hu...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Schedules of Controlled Substances: Placement of Centanafadine in Schedule III

On July 24, 2026, the United States Food and Drug Administration (FDA) approved a new drug applicati...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Essential Drug Delivery Performance Characteristics for Devices Intended To Deliver Drugs and Biological Products; Revised Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a revised draft g...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury (AKI) Dialysis Payment, and ESRD Quality Incentive Program

This final rule updates and revises the End-Stage Renal Disease (ESRD) Prospective Payment System fo...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances

The Secretary of the Department of Health and Human Services (HHS) is announcing the availability of...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Solicitation of Nominations for Appointment to the Advisory Committee on Immunization Practices

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Preventio...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; Anesthesiology Devices; Classification of the Over-the-Counter Device To Assess Risk of Sleep Apnea

The Food and Drug Administration (FDA) is classifying the over-the-counter device to assess risk of...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; Anesthesiology Devices; Classification of the Spinal Imaging System for Neuraxial Procedures

The Food and Drug Administration (FDA) is classifying the spinal imaging system for neuraxial proced...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; Radiology Devices; Classification of the Radiology Software for Referral of Findings Related to Fibrotic Lung Disease

The Food and Drug Administration (FDA) is classifying the radiology software for referral of finding...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medical Devices; General and Plastic Surgery Devices; Classification of the Software-Aided Adjunctive Diagnostic Device for Use by Physicians on Lesions Suspicious for Skin Cancer

The Food and Drug Administration (FDA) is classifying the software-aided adjunctive diagnostic devic...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Third Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661

The Food and Drug Administration (FDA or Agency) is extending the effective date of the notice publi...

Federal RegisterOriginal source
🇺🇸Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

From TAILORx to OPTIMA: Evolving Evidence for Genomically Guided Chemotherapy in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

PubMed Journal of Clinical Oncology RSSOriginal source
🇺🇸Researchpubmed.ncbi.nlm.nih.govTier 1 · Research record

Methylphenidate for Hematologic Cancer-Related Fatigue: A Randomized Clinical Trial

PubMed Journal of Clinical Oncology RSSOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Prosacea

Official structured record identifier: e5907672-3ee1-44d3-9c92-6345ad3f4238.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Fungicure Anti-Fungal Wash

Official structured record identifier: ba0cea2d-23ee-4725-abcf-72a62ad58176.

openFDA Drug LabelsOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Fatal Acute Intestinal Infarction Following Abrupt Dabigatran Withdrawal in Unrecognized Masked Polycythaemia Vera: Rebound Vascular Risk, Corporate Opacity, and Clinical Trial Safety Governance

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Severe Thrombocytopenia Induced by Re‐Exposure to Piperacillin/Tazobactam: A Case Report in Critically Ill Patient With COVID‐19

Europe PMCOriginal source